Skip to main content

Agenda

Saturday, June 8, 2024

5:00 pm - 8:00 pm (CT)

Registration

7:30 pm - 9:00 pm (CT)

Posters and Exhibits Reception

Sunday, June 9, 2024

12:15 pm (CT)

Industry Session Sponsored by Sanofi | Regeneron

A Treatment Option for Patients With Uncontrolled Moderate-to-Severe Atopic Dermatitis
Vivian Shi, MD, FAAD

4:00 pm (CT)

Opening Remarks

Jonathan I. Silverberg, MD, PhD, MPH

4:10 pm - 6:00 pm (CT)

Mini-Symposium 1: Therapeutic updates in AD: what you need to know right now!

Moderator: Jonathan I. Silverberg, MD, PhD, MPH

  • 4:10 pm

    Topical Therapy Revolution

    Robert Bissonnette, MD

  • 4:30 pm

    Systemic therapies coming soon

    Jonathan I. Silverberg, MD, PhD, MPH

  • 4:50 pm

    What can we use in our pediatric patients?
    Amy Paller, MD

  • 5:10 pm

    "Two for one": managing atopic comorbidities of atopic dermatitis
    Anne Marie Singh, MD

  • 5:30 pm

    "Two for one": managing autoimmune comorbidities of atopic dermatitis
    Jonathan I. Silverberg, MD, PhD, MPH

  • 5:50 pm

    Panel Discussion
    All Panelists

7:00 pm - 9:00 pm (CT)

Faculty and Trainee Mixer (TBA)

Monday, June 10, 2024

8:00 am (CT)

Industry Session Sponsored by AbbVie

9:00 am (CT)

Opening Remarks

Jonathan I. Silverberg, MD, PhD, MPH

9:05 am (CT)

Hot Topic: Guideline update from around the world

Robert Sidbury, MD, MPH

9:25 am - 10:40 am (CT)

Mini-Symposium 2: What's new in itch therapy for AD: are we there yet?

Moderator: Gil Yosipovitch, MD

  • 9:25 am

    Biomarkers for Itch in AD and beyond

    Leigh Nattkemper, PhD

  • 9:45 am

    How do approved therapies stack up?

    Raj Chovatiya, MD, PhD

  • 10:05 am

    State of the art in assessing itch and sleep in atopic dermatitis

    Gil Yosipovitch, MD

  • 10:25 am

    Panel Discussion

10:40 am - 12:00 pm (CT)

Mini-Symposium 3: Emerging therapeutics for atopic dermatitis: What to be on the lookout for?

Moderator: Raj Chovatiya, MD, PhD

  • 10:40 am

    Can we achieve remission with our current therapies?

    Raj Chovatiya, MD, PhD

  • 11:00 am

    New pathways being explored in atopic dermatitis

    Melinda Gooderham, MSc, MD, FRPC

  • 11:20 am

    Futuristic therapies for atopic dermatitis

    David Rosmarin, MD

  • 11:45 am

    Panel Discussion
    All Panelists

12:00 pm (CT)

RAD Tips & Tricks

All Faculty

12:30 pm (CT)

Break and Lunch

12:45 pm (CT)

Industry Session Sponsored by Lilly

Battle of the Two Titans Part III
Systemic Therapy: Who’s a Contender?
Jonathan I. Silverberg, MD, PhD, MPH and Melinda Gooderham, MSc, MD, FRPC

1:30 pm - 4:20 pm (CT)

Late-Breaking Research

Moderator: Jonathan I. Silverberg, MD, PhD, MPH

4:20 pm (CT)

Closing Remarks

Jonathan I. Silverberg, MD, PhD, MPH

(Agenda subject to change)